Test Early, Intervene, and Decrease Risks
of Cognitive Decline.
One in five individuals who develop dementia shows no signs of impairment in the early stages. Identify cognitive impairment risks in your members before symptoms appear, so you can intervene and slow the progression of the disease.
Cognitive impairment increases risk of hospital
30-day readmission by up to 47%
Cognitive impairment also increases the risk of hospital readmission by up to 47 percent, which translates to increased costs for you. Lower your cost of healthcare by identifying your members with cognitive impairment to help them better manage treatment for chronic diseases such as diabetes, Chronic Obstructive Pulmonary Disease (COPD), and more.
Savonix can help.
Our digital cognitive assessment is reliable and accurate, and detects mild cognitive impairment 93 percent of the time. Cognitive assessments take up to 30 minutes to complete.
Do you and your members know lifestyle factors can reduce the risk of cognitive decline? In fact, 40 to 60 percent of mild cognitive impairment is reversible if changes are made such as getting enough sleep, exercise, social interaction, and incorporating a healthy diet. After assessments are complete, you can use Savonix to provide advice and create personalized care plans to improve your customers’ cognitive health.
The Savonix Complete Payer Solution Includes:
Our HIPAA compliant dashboard allows you to view results, monitor changes, and manage access to Savonix tests. It can be accessed remotely from any mobile device or web. Through the dashboard, you can also access:
Our on-demand, personalized care plan generator, SavonixCare, combines the results of the member assessment with care plan components to streamline the clinical diagnosis and treatment process.
Our analytics tool designed by our team of data scientists and neuropsychologists, Savonix Insights, provides in-depth cognitive, demographic, and behavioral reports ranging from the population to individual-level information.